Autopsy report · NCT03514537
Autologous Stem/Stromal Cellular Stromal Vascular Fraction (cSVF) In Frailty-Aging Processes
Cause of deathStaffing, sites or logistics
“COVID -19 closed facility and testing of subjects”
Life of this trial
- Suspended: paused, and may or may not restart.
- 200 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Healeon Medical Inc
- Sponsor type
- Industry
- Conditions
- Frail Elderly Syndrome; Aging; Degenerative Disease
- Interventions
- Microcannula harvest adipose stromal tissues; Centricyte 1000; Sterile Normal Saline IV Deployment of cSVF; Liberase; Saline Solution
- Participants
- 200 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years
“Study closed in response to COVID-19 and overall program objectives.” - Tobacco Cessation for Sexual Minorities
“Covid-19 quarantines and closures prevented recruitment and assessment of participants.” - Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)
“COVID-19 Research Restrictions” - Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
“COVID-19 prevented us from doing this human subjects study” - The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
“The study closed prior to completing year 3 of the study due to the COVID-19 pandemic.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.